L Aerts1, M R Christiaens2, P Enzlin3, P Neven4, F Amant5. 1. Department of Obstetrics and Gynaecology, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium. Electronic address: aertsleen55@hotmail.com. 2. Multidisciplinary Breast Centre, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium. Electronic address: marie-rose.christiaens@uzleuven.be. 3. Centre for Clinical Sexology and Sex therapy, University Psychiatric Centre KU Leuven, Herestraat 49, 3000 Leuven, Belgium; Department of Neurosciences, Institute for Family and Sexuality Studies, University of Leuven, Herestraat 49, 3000 Leuven, Belgium. Electronic address: paul.enzlin@uzleuven.be. 4. Department of Obstetrics and Gynaecology, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium. Electronic address: patrick.neven@uzleuven.be. 5. Department of Obstetrics and Gynaecology, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium; Multidisciplinary Breast Centre, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium. Electronic address: frederic.amant@uzleuven.be.
Abstract
INTRODUCTION: Breast cancer (BC) and/or its treatments may affect sexual functioning based on physiological and psychosocial mechanisms. The aim of this study was to prospectively investigate sexual adjustment of BC patients during a follow-up period of one year after mastectomy (ME) or breast conserving therapy (BCT). METHODS: In this prospective controlled study, women with BC and an age-matched control group of healthy women completed the Beck Depression Inventory Scale, World Health Organization 5 Well-being scale, Body Image Scale, EORTC QLQ questionnaire, Dyadic Adjustment Scale, Short Sexual Functioning Scale and Specific Sexual Problems Questionnaire to assess various aspects of sexual and psychosocial functioning before surgery, six months and one year after surgical treatment. RESULTS: In total, 149 women with BC and 149 age-matched healthy controls completed the survey. Compared to the situation before surgery, significantly more BCT women reported problems with sexual arousal six months after surgery and significantly more women of the ME group reported problems with sexual desire, arousal and the ability to achieve an orgasm six months and one year after surgery. While in comparison with healthy controls, no significant differences in sexual functioning were found after BCT surgery, significantly more women who underwent ME reported problems with sexual desire, arousal, the ability to achieve an orgasm and intensity of the orgasm. CONCLUSIONS: Although little differences were seen in sexual functioning in the BCT group during prospective analyses and in comparison with healthy controls, analyses revealed that women who underwent a ME were at risk for post-operative sexual dysfunctions.
INTRODUCTION:Breast cancer (BC) and/or its treatments may affect sexual functioning based on physiological and psychosocial mechanisms. The aim of this study was to prospectively investigate sexual adjustment of BC patients during a follow-up period of one year after mastectomy (ME) or breast conserving therapy (BCT). METHODS: In this prospective controlled study, women with BC and an age-matched control group of healthy women completed the Beck Depression Inventory Scale, World Health Organization 5 Well-being scale, Body Image Scale, EORTC QLQ questionnaire, Dyadic Adjustment Scale, Short Sexual Functioning Scale and Specific Sexual Problems Questionnaire to assess various aspects of sexual and psychosocial functioning before surgery, six months and one year after surgical treatment. RESULTS: In total, 149 women with BC and 149 age-matched healthy controls completed the survey. Compared to the situation before surgery, significantly more BCT women reported problems with sexual arousal six months after surgery and significantly more women of the ME group reported problems with sexual desire, arousal and the ability to achieve an orgasm six months and one year after surgery. While in comparison with healthy controls, no significant differences in sexual functioning were found after BCT surgery, significantly more women who underwent ME reported problems with sexual desire, arousal, the ability to achieve an orgasm and intensity of the orgasm. CONCLUSIONS: Although little differences were seen in sexual functioning in the BCT group during prospective analyses and in comparison with healthy controls, analyses revealed that women who underwent a ME were at risk for post-operative sexual dysfunctions.
Authors: Leticia Aptecar; Frederic Fiteni; Marta Jarlier; Stephanie Delaine; Violaine Guillerme; William Jacot; Veronique D'Hondt Journal: Breast Cancer Res Treat Date: 2021-01-15 Impact factor: 4.872
Authors: Neha Verma; Amanda L Blackford; Elissa Thorner; Jennifer Lehman; Claire Snyder; Vered Stearns; Karen Lisa Smith Journal: Breast Cancer Res Treat Date: 2022-10-05 Impact factor: 4.624
Authors: Paulina Bajonero-Canonico; Ana S Ferrigno; Jorge A Saldaña-Rodriguez; David E Hinojosa-Gonzalez; Cristel G de la O-Maldonado; Carlos de la Cruz-de la Cruz; Brizio Moreno-Jaime; Mariela Hernandez-Pavon; Jose Moral-de la Rubia; Melina Miaja-Avila; Cynthia Villarreal-Garza Journal: Support Care Cancer Date: 2020-09-25 Impact factor: 3.603
Authors: Kayo Togawa; Huiyan Ma; Ashley Wilder Smith; Marian L Neuhouser; Stephanie M George; Kathy B Baumgartner; Anne McTiernan; Richard Baumgartner; Rachel M Ballard; Leslie Bernstein Journal: Sci Rep Date: 2021-05-21 Impact factor: 4.379
Authors: Coco J E F Walstra; Robert-Jan Schipper; Yvonne E van Riet; Peter-Paul G van der Toorn; Marjolein L Smidt; Maurice J C Vd Sangen; Adri C Voogd; Grard A P Nieuwenhuijzen Journal: Breast Cancer Res Treat Date: 2021-03-13 Impact factor: 4.872
Authors: Susanna B Hummel; Jacques J D M van Lankveld; Hester S A Oldenburg; Daniela E E Hahn; Eva Broomans; Neil K Aaronson Journal: BMC Cancer Date: 2015-04-28 Impact factor: 4.430
Authors: Christina M Dudley; Alyssa A Wiener; Trista J Stankowski-Drengler; Jessica R Schumacher; Amanda B Francescatti; Samuel O Poore; Caprice C Greenberg; Heather B Neuman Journal: Clin Breast Cancer Date: 2021-03-27 Impact factor: 3.078